Bringing together a talented mix of academic, biopharma and healthcare professionals, the Festival of Genomics, this year hosted in London from 31st January – 1st February, aims to bring the benefits of genomics to patients faster. Attendees at the two-day event will have the opportunity to explore the power of the genome in driving R&D and the diagnosis and treatment of disease into the future.
With conference themes including; Genomics in the Clinic, Genetic counselling in the genomics era & Whose genome is it anyway? This year’s event is set to focus heavily on empowering individuals to bring the value of genomics into every day clinical practice.
Highlights to look forward to include Dr. Joaquin Dopazo, head of the Computational Genomics Department at CIPF, Valencia, Spain. During his keynote, Dr. Dopazo will share the work he is doing to improve the clinical understanding of how diseases are evolving in the context of the wider population. This will see him discuss the need for a database of allelic variation in the local population and how it will transform the future provision of healthcare.
In addition, there will be an update on the Qatar Genome Program, a large-scale, high impact project that’s just completed its pilot phase.
Ensuring all stakeholders understand how to properly analyse, share and integrate data at scale will be a defining factor for the future success of biology, medicine and genome methods, and an important topic for discussion at the Festival of Genomics.
The Enabling Data theme should reveal the potential for advanced analytics/AI to help cure complex diseases. Whilst the Global Alliance for Genomics & Health GA4GH’s work to improve data sharing, reinvent the reference genome and unlock the potential of genomics on a global scale will likely influence conversations around future industry innovation.
ELIXIR will have a strong presence at the festival. ELIXIR connects national bioinformatics centres and EMBL-EBI to build a sustainable European infrastructure for biological research data. ELIXIR activities in Human Genomics and Translational Data led by Serena Scollen focus on sustainable solutions for the storage, discovery and exchange of human data to enable re-use by the scientific community and impact medicine globally. Learn more about ELIXIR at booth 35.
The benefits of genomics are already being felt in the improvement of patients’ wellbeing, diagnosis and efficacy of treatment. Events such as the Festival of Genomics are crucial to accelerating this impact and supporting scientists, clinicians, business and research leaders in their individual activities.
As the first major event in the Health and Life Sciences calendar for this year I am excited to see what learnings and insights will emerge. With such a diverse programme of speakers to choose from, there are sure to be many in-depth conversations across the two-days, which will help shape the direction our industry takes over the course of the next 12 months.
Intel is co-exhibiting at the Festival of Genomics alongside Atos. For more information on the event itself you can view the full programme here or to speak to one of our team, visit us at Stand 15.
- Read more about Intel Health and Life Sciences
- Join the discussion @IntelHealth
- Latest health IT news: Sign up for the Intel Newsletter
- Contact the author on LinkedIn